<DOC>
	<DOCNO>NCT00805311</DOCNO>
	<brief_summary>The aim study determine whether optimal medical treatment postpone carotid endarterectomy .</brief_summary>
	<brief_title>Aggressive Medical Treatment Evaluation Asymptomatic Carotid Artery Stenosis</brief_title>
	<detailed_description>It well know risk fatal non-fatal stroke increase patient significant carotid atherosclerosis . For asymptomatic patient , AHA guideline recommend carotid endarterectomy ( CEA ) stenosis 60 % 99 % , risk perioperative stroke death le 3 % . Although clinical trial data support CEA asymptomatic patient carotid stenosis 60 % 79 % , AHA guideline indicate physician delay revascularization great 80 % stenosis asymptomatic patient . Our study design determine whether optimal medical therapy alone reduce risk death nonfatal stroke patient carotid artery stenosis compare CEA couple optimal medical therapy .</detailed_description>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Carotid Stenosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Unilateral bilateral carotid artery stenosis consider severe ( carotid artery diameter reduction 70 % 79 % ultrasound ) This stenosis cause stroke , transient cerebral ischaemia , relevant neurological symptom past 6 month Both doctor patient substantially uncertain whether choose immediate CEA , deferral CEA definite need think arisen The patient know circumstance condition likely preclude longterm followup Neurologist 's explicit consent potentially perform CEA Previous ipsilateral CEA Expectation poor surgical risk ( e.g. , recent acute myocardial infarction ) Some probable cardiac source embolus ( main stroke risk might cardiac , carotid , embolus ) Inability provide inform consent Underlying disease atherosclerosis ( inflammatory autoimmune disease ) Life expectancy &lt; 6 month Advanced dementia Advanced renal failure ( serum creatinine &gt; 2.5 mg/dL ) Unstable severe cardiovascular comorbidities ( e.g. , unstable angina , heart failure ) Restenosis prior CAS CEA Atrial fibrillation Allergy contraindication study medication ( statin , ASA , losartan , amlodipine )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Internal Carotid Artery Stenosis</keyword>
	<keyword>Carotid Endarterectomy</keyword>
	<keyword>Stroke</keyword>
	<keyword>Cerebrovascular</keyword>
	<keyword>Atherosclerosis</keyword>
</DOC>